Physician profile
Mandy Fields Starbuck
NPI 1245564160
$13,082.98
in general payments reported to CMS, 2019-2025
37 companies · $1,461 in 2025
The $1,461 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,346 · 2022: $3,022 · 2023: $1,762 · 2024: $1,492 · 2025: $1,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,714.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,890.36 | 2021-2025 | Cardiomems, Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $1,068.59 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $736.33 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $652.42 | 2021-2025 | Brilinta, Farxiga, Wainua |
| Amgen INC. | $604.69 | 2021-2025 | Repatha, Repatha, Otezla |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $502.52 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $388.09 | 2021-2025 | Bodyguardian, Watchman Flx, Watchman Access System |
| Pfizer INC. | $375.55 | 2021-2024 | |
| Novo Nordisk INC | $346.26 | 2021-2025 | Wegovy, Ozempic |
| Sanofi-Aventis U.S. LLC | $296.93 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $254.98 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $236.49 | 2022-2025 | Jardiance |
| Cvrx, INC. | $236.31 | 2023-2025 | Barostim Neo System |
| Recor Medical INC | $184.32 | 2025 | Paradise Ultrasound Renal Denervation System |
| Amarin Pharma, INC. | $162.49 | 2021-2023 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Starbuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.